[Federal Register Volume 62, Number 99 (Thursday, May 22, 1997)]
[Notices]
[Pages 28037-28042]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13425]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Announcement 752]
Health Services Research on Sexually Transmitted Diseases
Prevention Within Managed Care Settings
Introduction
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 1997 funds for applied health services
research projects on sexually transmitted diseases (STDs) prevention
within managed care settings.
CDC is committed to achieving the health promotion and disease
prevention objectives of ``Healthy People 2000,'' a national activity
to reduce morbidity and mortality and improve the quality of life. This
announcement is related to the priority area of Sexually Transmitted
Diseases (STDs). (To order a copy of ``Healthy People 2000,'' see the
Section ``WHERE TO OBTAIN ADDITIONAL INFORMATION.'')
Authority
This program is authorized under Section 318 of the Public Health
Service Act (42 U.S.C. 247C), as amended.
Smoke-Free Workplace
CDC strongly encourages all grant recipients to provide a smoke-
free workplace and to promote the non-use of all tobacco products, and
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in
certain facilities that receive Federal funds in which education,
library, day care, health care, and early childhood development
services are provided to children.
Eligible Applicants
Applications may be submitted by public and private, nonprofit and
for-profit organizations and governments and their agencies. Thus,
universities, colleges, research institutions, hospitals, other public
and private organizations, State and local health departments or their
bona fide agents or instrumentalities, federally recognized Indian
tribal governments, Indian tribes or Indian tribal organizations,
small, minority, or women-owned businesses, managed care organizations
and clinical public health entities such as: sexually transmitted
disease (STD) clinics and family planning clinics are eligible to
apply.
Applications from health departments, Indian tribal governments,
academic institutions, and contractors will be required to demonstrate
partnership with a managed care organization, and applications from
managed care organizations will be required to demonstrate partnership
with a State or local health department. All eligible applicants must
have research capacity involving previous experience with health
services research, and access to relevant clinic populations such as
adolescents, women, minorities, and Medicaid populations.
Availability of Funds
Approximately $650,000 is available in FY 1997 to fund up to a
total of five awards in four research areas. It is expected that the
average award will be $200,000, ranging from $100,000 to $300,000.
Specifically, organizations may submit applications in EACH or ANY of
the following four research areas:
1. STD-Managed Care Prevention Services Survey. (1 year funding)
2. Quality of Service Studies. (2-3 years funding)
3. Notifiable Disease Reporting and Information Systems Studies.
(2-3 years funding)
4. Population-Level STD Prevention Studies. (2-3 years funding)
It is expected that awards will begin on or about September 15,
1997, and will be made for a 12-month budget period within a one to
three year project period. Funding estimates may vary and are subject
to change. Continuation awards within the project period will be made
on the basis of satisfactory progress and the availability of funds.
Use of Funds
Funds are awarded for a specifically defined purpose and may not be
used for any other purpose or program. Funds may be used to support
personnel and to purchase equipment, supplies, and services directly
related to project activities. Funds may not be used to supplant State
or local health department funds or for inpatient care, medications, or
construction.
Restricitons on Lobbying
Applicants should be aware of restrictions on the use of HHS funds
for
[[Page 28038]]
lobbying of federal or state legislative bodies. Under the provisions
of 31 U.S.C. Section 1352 (which has been in effect since December 23,
1989), recipients (and their subtier contractors) are prohibited from
using appropriated federal funds (other than profits from a federal
contract) for lobbying Congress or any federal agency in connection
with the award of a particular contract, grant, cooperative agreement,
or loan. This includes grants/cooperative agreements that, in whole or
in part, involve conferences for which federal funds cannot be used
directly or indirectly to encourage participants to lobby or to
instruct participants on how to lobby.
In addition, the FY 1997 HHS Appropriations Act, which became
effective October 1, 1996, expressly prohibits the use of 1997
appropriated funds for indirect or ``grass roots'' lobbying efforts
that are designed to support or defeat legislation pending before state
legislatures. This new law, Section 503 of Pub. L. No. 104-208,
provides as follows:
Sec. 503(a) No part of any appropriation contained in this Act
shall be used, other than for normal and recognized executive-
legislative relationships, for publicity or propaganda purposes, for
the preparation, distribution, or use of any kit, pamphlet, booklet,
publication, radio, television, or video presentation designed to
support or defeat legislation pending before the Congress, * * * except
in presentation to the Congress or any State legislative body itself.
(b) No part of any appropriation contained in this Act shall be
used to pay the salary or expenses of any grant or contract recipient,
or agent acting for such recipient, related to any activity designed to
influence legislaiton or appropriations pending before the Congress or
any State legislature. Department of Labor, Health and Human Services,
and Education, and Related Agencies Appropriations Act, 1997, as
enacted by the Omnibus Consolidated Appropriations Act, 1997, Division
A, Title I, Section 101(e), Pub. L. No. 104-208 (September 30, 1996).
Background
The recent Institute of Medicine (IOM) report ``The Hidden
Epidemic: Confronting Sexually Transmitted Diseases'' (NAP 96)
concluded that STDs represent a tremendous health and economic burden
in the United States (U.S.). That committee recommended that
comprehensive high quality STD-related health services be available to
all persons.
Managed care represents a revolution in the way health care is
funded, organized, and delivered in the U.S. This has and will continue
to have impact on the way in which STD prevention is conducted in both
the private and public sectors. In the public sector, many health
departments are in some stage of transition from directly delivering
clinical services in categorical clinics to utilizing other delivery
models that involve managed care. Thus, in the private sector, managed
care providers play a key role in the way STDs are diagnosed and
managed for increasing numbers of Americans. With more diagnostic and
treatment services for STDs moving into the private sector, new
partnerships are needed between Managed Care health plans and public
health agencies to design and implement essential STD-related services
in innovative ways.
Purpose
The purpose of this applied health services research program is to
develop a knowledge base through published research in scientific
literature which will improve delivery of STD prevention services
within managed care settings. Such a knowledge base includes a variety
of activities covering the range of STD interventions, such as risk
assessment, screening asymptomatically infected persons, early
diagnosis of infected persons, treatment, partner notification and
management, notification of reportable diseases, counseling, and
laboratory services.
This program also seeks to improve the availability, accessibility,
delivery, quality, effectiveness, cost-effectiveness, and outcomes of
STD prevention services in managed care health plans. The objectives
include provision of data for policy development, assessment, and
capacity building at the State and local level with respect to managed
care and the health department's ability to develop appropriate STD
prevention policies and to conduct STD surveillance in a changing
environment.
It is anticipated that an additional benefit will be to establish
new partnerships and relationships between managed care health plans
and public health agencies that will collaboratively address the
challenges of improving the delivery of STD treatment and prevention
services.
Program Requirements
Work performed under this agreement will be the result of
collaborative efforts. Recipients will be responsible for research
methods and design, analysis, use of data and dissemination via peer
publications or other related material. CDC will coordinate these
collaborative efforts and expects to work closely with each award
recipient.
In conducting activities to achieve the purpose of this program,
the recipient will be responsible for the activities under A.
(Recipient Activities), and CDC will be responsible for the activities
under B. (CDC Activities).
A. Recipient Activities
In conducting activities to achieve the purpose of this program,
the recipient will:
1. STD-Managed Care Prevention Services Survey:
Develop a nationally representative health services survey
examining the extent and characteristics of STD care that occur within
managed care health plans. The survey is expected to address the
following questions:
a. How alternative managed care systems affect access and
utilization, quality, cost and outcomes of STD-related treatment and
prevention services. This would address issues related to laboratory,
screening, counseling, treatment, health promotion, STD case
management, partner management. This would also address the extent to
which diagnosis and treatment of STDs is syndromic (i.e., presumptive
STD diagnosis and empirical treatment based on symptoms and physical
examination alone).
b. How STD care and delivery of prevention services vary with
organization, structure, and financing of health plans, specifically
with respect to type of services offered, access, and quality
(including patient satisfaction). For example:
(1) Address the characteristics (including demographic
characteristics such as age, race/ethnicity, income, occupation,
socioeconomic status, type of insurance) of those enrolled. Also
address the characteristics of those actually receiving care (e.g.,
what is the coverage?), and discuss how plans target adolescents,
women, high-risk patients, and underserved population groups of
interest.
(2) Address the organizational linkages to essential components of
STD services not provided by a health plan (e.g., partner notification,
counseling). Also address whether or not referral is occurring, and how
is it handled (e.g., what is the nature of the referral arrangements?)
2. Quality of Service Studies:
Conduct studies to improve the quality of STD prevention services
to promote early detection, effective
[[Page 28039]]
treatment, and follow up of STDs within managed care health plans.
Projects should consider how the information could be used by consumers
and purchasers to improve decision making. One or both of the following
items must be addressed:
a. Develop and test STD-related performance measures and other
quality measurement tools to improve quality assurance monitoring in
health plans and other clinical venues. Recipients will address the
issue of data and use of information systems that support the
assessment, analysis and evaluation aspects of performance monitoring.
b. Conduct demonstration projects that will improve access to high-
quality STD-related services. These may focus on interventions for
providers or for patients, and may address issues of access, screening,
diagnosis, treatment, counseling and education, or partner management.
Recipients should pay special attention to the effectiveness and
outcomes of the interventions studied.
3. Notifiable Disease Reporting and Information Systems Studies:
Conduct studies to develop and evaluate information systems that
can meet the internal data requirements of managed care plans while
improving the completeness and accuracy of surveillance and disease
reporting activities of the plan. Recipients should:
a. Assess the current status of electronic information systems in
the health plan and associated health department, document their
characteristics, and determine the feasibility for data sharing.
Elements to be considered are: disease (morbidity) data, laboratory
data, encounter data, pharmacy data, and use of and integration with
existing systems such as sexually transmitted diseases management
information system (STD*MIS), national electronic transmission
surveillance (NETS), health plan and employer data information set
(HEDIS), public health laboratory information system (PHLIS), or other
equivalent State health department data collection system.
b. Address the issues of confidentiality of data and the use of
data for reimbursement of services provided by health departments.
4. Population-Leveled STD Prevention Studies:
Conduct studies that involve the development and testing of
interventions based on collaborative partnerships to achieve
population-level goals (e.g., to decrease transmission and not just
treat symptoms and prevent sequelae). One or both of the following
items must be addressed:
a. How managed health care plans can adopt public health preventive
measures. An example of this would be to develop and evaluate methods
for plans to effectively manage sex partners of members who are
diagnosed with an STD to prevent re-infection and reduce further
transmission. Another example would be to develop and evaluate methods
for provider-based counseling or education.
b. How managed health care plans can target or reconfigure existing
services to reduce disease transmission within the community. An
example of this would be to develop and evaluate methods for screening
health plan members at risk for STDs who do not otherwise present for
care. Another example would be to develop cost-effective risk
assessment and targeted screening protocols for use in primary care
settings to reduce the incidence of pelvic inflammatory disease.
B. CDC Activities
1. Assist recipients to develop, pilot test, and implement
protocols and instruments.
2. Provide scientific and technical guidance in the general
operations.
3. Provide advice in monitoring and evaluating scientific and
operational accomplishments.
4. Assist in data analysis and presentation and reporting of
research materials and results.
5. Monitor the recipient's performance of program activities,
protection of client confidentiality and compliance with other
requirements.
6. Provide technical assistance that may be needed to improve
electronic data transmission between reporting organizations and
associated health departments.
Technical Reporting Requirements
An original and two copies of a quarterly progress report must be
submitted no later than 30 days after the end of each budget quarter.
An original and two copies of a financial status report (FSR) is
required no later than 90 days after the end of each budget period. A
final progress report and FSR are due no later than 90 days after the
end of the project period. All reports will be submitted to the Grants
Management Branch, CDC.
Application Content
Applicatons must be developed in accordance with PHS Form 5161-1
(OMB Number 0927-0189), information contained in the program
announcement, and the instructions and format provided below.
Applicants are required to submit an original and two copies of the
application. Number each page clearly and sequentially, and provide a
complete index to the application and its appendices. The original and
each copy of the application set must be submitted UNSTAPLED and
UNBOUND. All material must be typewritten, double spaced, with
unreduced type on 8\1/2\'' by 11'' paper, with at least 1'' margins,
headings and footers, and printed on one side only. Materials which
should be part of the basic application will not be accepted if placed
in the appendices.
If an applicant responds to more than one research area, each
research area must be addressed separately, including a separate
project-specific narrative, budget, and attachments.
The application must include an executive summary not to exceed
four pages. The application must also include:
1. Background
a. Describe the STD clinical and preventive health services
available in the community and within the managed care health plan.
b. Describe the epidemiology of gonorrhea, chlamydia, and primary
and secondary (P&S) syphilis in calendar year 1995 for the proposed
project area.
c. Describe those at risk for STDs and their access to health care,
the percentage uninsured, unemployed, under the poverty level, and
those receiving Temporary Assistance for Needy Families (TANF),
formerly Aid to Families with Dependent Children.
d. Describe the managed care system and extent of managed care
penetration and competition with the local or regional health care
market. Describe the managed care structure, organization and
financing, and the percentage of Medicaid population under managed care
contracts and of those at risk for STDs under managed care contracts.
e. Include additional background on any health care reform
legislation, policies and additional environmental and socio-
demographic factors that may be relevant to the study of STD services
in managed care. Examples include privatiization of categorical STD
clinics, existing or pending Federal Medicaid waivers, and the extent
to which existing Medicaid managed care contracts address public health
issues, existing contracts, memoranda of understanding, agreements or
arrangements between health plans and health departments.
[[Page 28040]]
2. Site Selection
Define a project area based on specific information included in the
background.
3. Objectives
Provide a focused research agenda with long-term and short-term
objectives that is realistic, specific, measurable, time-phased, and
consistent with the objectives of the announcement.
4. Methods
Described the methods and activities that will be undertaken to
accomplish the objectives, including, where applicable, outcomes to be
evaluated (i.e., health services-related outcomes, program-related
outcomes, or STD specific health-related outcomes), the use of
appropriate comparison groups, the sampling scheme and sample size
calculations, qualitative and quantitative methods, and how data will
be accessed, collected and used.
5. Evaluation Plan
Applications must provide an evaluation plan to monitor the
effectiveness of the project activities and the progress made towards
meeting the objectives.
6. Partnerships
Applications from health departments, academic institutions, and
contractors will be required to demonstrate partnership with a managed
care organization. Applications from managed care organizations will be
required to demonstrate partnership with a State or local health
department.
Provide evidence of partnership and documentation of the commitment
of collaborating organizations, agencies or individual researchers.
Include letters summarizing the nature of the collaboration and
indicating support. Letters should be signed by the chair of an
academic department and the Dean of the institution; the STD program
manager and director of communicable disease control or health officer;
the director of research (if applicable), and medical director or other
senior officer of the health plan.
7. Research Capacity
Provide evidence of health services research capability. Describe
past and current research experience, including the experience of the
proposed staff who will participate in this project (include details of
experience and competence in research design, data collection, analysis
and dissemination). Attach the curriculum vitae of key staff. Describe
your plan for project administration.
The research team should include qualified and experienced
personnel. Health services research is an interdisciplinary field
drawing on theory and methods from biostatistics, epidemiology,
medicine, health economics, sociology, operations research, psychology,
nursing, and other disciplines. Thus, qualified researchers may come
from a variety of fields but must have appropriate training and
experience, and previous involvement with health services research
projects. Minimum requirements for the research team are a principle
investigator, statistician, and data manager.
8. Access to Populations At Rick For STDs
Applications must also provide evidence of access to relevant
clinic populations such as adolescents, women, minorities, and Medicaid
populations.
9. Budget
Provide a detailed, line-item budget for the project and a budget
narrative that justifies each line-item.
Review and Evaluation Criteria
If an applicant applies for more than one research area, each
proposal will be evaluate separately. Applications will be reviewed and
evaluated according to the following criteria:
1. Background and Objectives (15 points)--Understanding of purpose
and objectives of this research as reflected in the statement of
research background and research questions.
2. Site Selection (10 points)--The extent to which the choice of a
site to conduct this research is appropriate to the objectives, STD
epidemiology, social demography, and managed health care system.
Emphasis will be placed on demonstrated access to one or more
populations considered at high risk for STDs and their complications,
including adolescents, women, minorities, or Medicaid enrollees in the
project area.
3. Methods (25 points)--The appropriateness and adequacy of the
research design and methodology proposed to answer the research
questions. This includes: (a) the selection of appropriate outcomes
related to health services, STD programs, and STD morbidity; (b) the
use of appropriate comparison groups; (c) the inclusion of appropriate
sampling schemes, sample size calculation, handling of sampling biases;
(d) access to the relevant data sources and the plan for data
collection and; (e) the description of the specific quantitative and
qualitative analytic technique to be used to answer the research
questions.
4. Evaluation (10 points)--The extent to which the applications
present a sound evaluation plan that includes aspects such as: research
progress measurements and communications, baseline data collection;
intervention(s) testing, determination of intervention(s)
effectiveness; and economic evaluation.
5. Partnerships (20 points)--The extent to which the proposed
research is interdisciplinary, programmatically relevant, and
establishes effective collaborative partnership arrangements necessary
for the research. The extent to which the application includes letters
from the appropriate persons summarizing the nature of the
collaboration and indicating support.
6. Research Capacity (20 points)--Overall ability to perform the
technical aspects of the project including: (a) the availability of
qualified and experienced personnel for a multi-disciplinary team in
health services research (including level of education and training,
and relevant research experience of the principle investigator and key
research personnel; (b) the availability of adequate facilities,
general environment, and resources for the conduct of the proposed
research and; (c) plans for the administration of the project(s),
including a detailed and realistic schedule for the specified
activities.
7. Budget (not scored)--The appropriateness of budget estimates in
relation to the proposed research. The extent to which budget is
reasonable, clearly justified, and consistent with the intended use of
funds.
Funding Preferences
CDC reserves the right to make final funding selections based on
geographic diversity, the level of STD in an applicants area/
jurisdiction, and coverage of the research activities across
applications. Matching funds: applicants are asked to demonstrate a
commitment to provide matching funding with a letter from a private
source, such as a foundation or managed care organization. Preference
will be given to those with 1:1 Federal to private funds ratio, with
more preference given to those with greater levels of private matching
funds.
Executive Order 12372 Review
Applications are subject to Intergovernmental Review of Federal
Programs as governed by Executive Order (E.O.) 12372. E.O. 12372 sets
up a system for State and local government review of proposed Federal
assistance applications. Applicants (other than
[[Page 28041]]
federally recognized Indian tribal governments) should contact their
State Single Point of Contact (SPOC) as early as possible to alert them
to the prospective applications and receive any necessary instructions
on the State process. For proposed projects serving more than one
State, the applicant is advised to contact the SPOC for each affected
State. A current list of SPOCs is included in the application kit. If
SPOCs have any State process recommendations on applications submitted
to CDC, they should send them to Van Malone, Grants Management Officer,
Grants Management Branch, Procurement and Grants Office, Centers for
Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE,
Atlanta, GA 30305, no later than 60 days after the application
deadline. The Program Announcement Number and Program Title should be
referenced on the document. The granting agency does not guarantee to
``accommodate or explain'' State process recommendations it receives
after the date.
Indian tribes are strongly encourage to request tribal government
review of the proposed application. If tribal governments have any
tribal process recommendations on applications submitted to CDC, they
should send them to Van Malone, Grants Management Officer, Grants
Management Branch, Procurement and Grants Office, Centers for Disease
Control and Prevention (CDC), 255 East Paces Ferry Road, NE, Atlanta,
GA 30305, no later than 60 days after the application deadline. The
Program Announcement Number and Program Title should be referenced on
the document. The granting agency does not guarantee to ``accommodate
or explain'' State process recommendations it receives after that date.
Public Health System Reporting Requirements
This program is not subject to the Public Health System Reporting
Requirements.
Catalog of Federal Domestic Assistance
The Catalog of Federal Domestic Assistance number is 93.978.
Other Requirements
Paperwork Reduction Act
Projects that involve the collection of information from 10 or more
individuals and funded by the cooperative agreement will be subject to
review by the Office of Management and Budget (OMB) under the Paperwork
Reduction Act.
Human Subjects
If the proposed project involves research on human subjects, the
applicant must comply with the Department of Health and Human Services
Regulations, 45 CFR Part 46, regarding the protection of human
subjects. Assurance must be provided to demonstrate that the project
will be subject to initial and continuing review by an appropriate
institutional review committee. In addition to other applicable
committees, Indian Health Service (IHS) institutional review committees
also must review the project if any component of IHS will be involved
or will support the research. If any American Indian community is
involved, its tribal government must also approve that portion of the
project applicable to it. The applicant will be responsible for
providing assurance in accordance with the appropriate guidelines and
form provided in the application kit.
Confidentiality
Any personally identifying information obtained in connection with
the delivery of services provided to any individual under any program
that is being carried out with a cooperative agreement made under this
announcement shall not be disclosed unless required by a law of a State
or political subdivision or unless such an individual provides written,
voluntary informed consent.
Women, Racial and Ethnic Minorities
It is the policy of the Centers for Disease Control and Prevention
(CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR)
to ensure that individuals of both sexes and the various racial and
ethnic groups will be included in CDC/ATSDR-supported research projects
involving human subjects, whenever feasible and appropriate. Racial and
ethnic groups are those defined in OMB Directive No. 15 and include
American Indian, Alaska Native, Asian, Pacific Islander, Black and
Hispanic. Applicants shall ensure that women, racial and ethnic
minority populations are appropriately represented in applications for
research involving human subjects. Where clear and compelling rationale
exist that inclusion is inappropriate or not feasible, this situation
must be explained as part of the application. This policy does not
apply to research studies when the investigator cannot control the
race, ethnicity and/or sex of subjects. Further guidance to this policy
is contained in the Federal Register Vol. 60, No. 179, pages 47947-
47951, dated Friday, September 15, 1995.
Application Submission and Deadlines
1. Preapplication Letter of Intent (LOI)
A non-binding letter of intent-to-apply is requested from potential
applicants. An original and two copies of a two-page, typewritten LOI
should be submitted to the Grants Management Branch, CDC (see
``Applications'' for address). It should be postmarked no later than
June 13 1997. The letter should identify the announcement number, title
of the specific research activity for which application is being
submitted, the name and institutional affiliation of the principal
investigator, and the identity of other key participants and
participating institutions. No attachments, booklets, or other
documents accompanying the LOI will be considered. The letter should
also include the estimated total cost of the research activity and the
percentage of the total cost being requested from CDC. The LOI does not
influence review of funding decisions, but it will enable CDC to plan
more efficiently, and will ensure that each applicant receives timely
and relevant information prior to application submission.
2. Applications
An original and two copies of the application Form PHS-5161-1 (OMB
Number 0937-0189) must be submitted on or before July 25, 1997 to Van
Malone, Grants Management Officer, Attention: Kathy Raible, Grants
Management Specialist, Grants Management Branch, Procurement and Grants
Office, Centers for Disease Control and Prevention (CDC), 255 East
Paces Ferry Road, NE., Room 300, Mailstop E-15, Atlanta, GA 30305.
3. Deadlines
A. Applications will meet the deadline if they are either:
1. Received on or before the deadline date; or
2. Sent on or before the deadline date and received in time for
submission to the objective review committee. (Applicants must request
a legibly dated U.S. Postal Service postmark or obtain a legibly dated
receipt from a commercial carrier or U.S. Postal Service. Private
metered postmarks shall not be acceptable as proof of timely mailing.)
B. Applications that do not meet the criteria in 3.A.1 or 3.A.2.
above are considered late applications. Late applications will not be
considered in current competition and will be returned to the
applicant.
[[Page 28042]]
Where To Obtain Additional Information
A complete application package which will include program
description, information on application procedures, etc. and business
management technical assistance may be obtained from Kathy Raible,
Grant Management Specialist, Grants Management Branch, Procurement and
Grants Office, Centers for Disease Control and Prevention (CDC), 255
East Paces Ferry Road, NE., Room 300, Mailstop E-15, Atlanta, GA 0305,
telephone 404) 842-6592, email or via email at: kcr8@cdc.gov>.
Programmatic technical assistance may be obtained from William J.
Kassler, M.D., M.P.H., Chief Health Services Research and Evaluation
Branch Division of STD, National Center for HIV/STD/TB
Prevention (NCHSTP), Centers for Disease Control and Prevention
(CDC), 1600 Clifton Road; Mailstop E-44, Atlanta, GA 30333, telephone
(404) 639-8276, or facsimile (404) 639-8607, INTERNET address:
wxkl@cdc.gov>.
Internet Home Page
The announcement will be available on one of two Internet sites on
the publication date: CDC's home page at http://www.cdc.gov>, or at
the Government Printing Office home page (including free access to the
Federal Register) at http://www.access.gpo.gov>.
Potential applicants may obtain a copy of ``Healthy People 200''
(Full Report, Stock No. 017-001-00474-0), or ``Healthy People 2000''
(Summary Report, Stock No. 017-001-00473-1) referenced in the
``INTRODUCTION'' through the Superintendent of Documents, Government
Printing Office, Washington, DC 20402-9325, telephone (202) 512-1800.
Dated: May 16, 1997.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 97-13425 Filed 5-21-97; 8:45 am]
BILLING CODE 4163-18-M
